Topics

. @Passage_Bio says $125M #IPO will fund development of gene therapies for rare monogenic CNS diseases: http://ow.ly/Fk1w50ycrqv pic.twitter.com/c1MJ2WqkgG

21:55 EST 3 Feb 2020 | Genetic Engineering News

. says $125M will fund development of gene therapies for rare monogenic CNS diseases: http://ow.ly/Fk1w50ycrqv 

Original Article: . @Passage_Bio says $125M #IPO will fund development of gene therapies for rare monogenic CNS diseases: http://ow.ly/Fk1w50ycrqv pic.twitter.com/c1MJ2WqkgG

NEXT ARTICLE

More From BioPortfolio on ". @Passage_Bio says $125M #IPO will fund development of gene therapies for rare monogenic CNS diseases: http://ow.ly/Fk1w50ycrqv pic.twitter.com/c1MJ2WqkgG"

Quick Search

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...